Lymphoma & Plasma Cell Disorders
News
Advanced cancer patients have lower survival after cardiac arrest
A new study suggests patients with advanced cancer who suffer cardiac arrest in the hospital have a survival rate of less than 10%, which is about...
News
Database may provide insight into childhood cancers
A database containing information on more than 11,000 tumors is now available to researchers studying pediatric cancers. The database was created...
Latest News
Solid organ transplantation contributes significantly to incidence of NHL among children and adolescents
The incidence of NHL for the pediatric transplant population was 257 times higher than that found in the general pediatric population.
News
FDA grants priority review of acalabrutinib for second-line treatment of MCL
Acalabrutinib for treatment of patients with mantle cell lymphoma has been granted priority review by the FDA.
News
Delirium linked to early death in advanced cancer patients
A diagnosis of delirium during a visit to the emergency department (ED) is a poor prognostic factor for patients with advanced cancer, according...
News
FDA grants acalabrutinib breakthrough designation
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to acalabrutinib, a BTK inhibitor being developed to treat...
CME
Clinical Endpoints in PTCL: The Road Less Traveled
News
Understanding childhood cancer in sub-Saharan Africa
Researchers say they have published the most extensive data ever collected on childhood cancer in sub-Saharan Africa. On the African continent,...
News
ASCO updates guidelines on antiemetic use in cancer patients
The American Society of Clinical Oncology (ASCO) has updated its clinical practice guidelines on the use of antiemetics in cancer patients. The...
News
Developing better mouse models
Researchers say they have developed a new approach to model human immune variation that overcomes the limitations of traditional mouse models....
From the Journals
Less lenalidomide may be more in frail elderly multiple myeloma patients
Starting patients on a reduced dose and increasing it gradually while monitoring carefully for adverse events, meant patients did not have to stop...